Centene Corporation (CNC)
| Market Cap | 33.97B +108.4% |
| Revenue (ttm) | 180.41B +7.6% |
| Net Income | 1.46B |
| EPS | 2.95 |
| Shares Out | 495.07M |
| PE Ratio | 23.25 |
| Forward PE | 13.35 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,628,640 |
| Open | 68.25 |
| Previous Close | 67.05 |
| Day's Range | 67.08 - 68.86 |
| 52-Week Range | 31.63 - 72.50 |
| Beta | 1.13 |
| Analysts | Buy |
| Price Target | 74.50 (+8.57%) |
| Earnings Date | Oct 27, 2026 |
About CNC
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and servi... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 21 analysts, the average rating for CNC stock is "Buy." The 12-month stock price target is $74.5, which is an increase of 8.57% from the latest price.
News
Centene price target raised to $75 from $69 at Wells Fargo
Wells Fargo raised the firm’s price target on Centene (CNC) to $75 from $69 and keeps an Equal Weight rating on the shares. The firm says results in Q3 were…
Centene price target raised to $75 from $67 at JPMorgan
JPMorgan analyst John Stansel raised the firm’s price target on Centene (CNC) to $75 from $67 and keeps a Neutral rating on the shares.
Centene price target raised to $78 from $70 at UBS
UBS raised the firm’s price target on Centene (CNC) to $78 from $70 and keeps a Neutral rating on the shares.
Centene price target raised to $71 from $66 at Morgan Stanley
Morgan Stanley analyst Erin Wright raised the firm’s price target on Centene (CNC) to $71 from $66 and keeps an Equal Weight rating on the shares.
Centene price target raised to $79 from $75 at Cantor Fitzgerald
Cantor Fitzgerald analyst Sarah James raised the firm’s price target on Centene (CNC) to $79 from $75 and keeps an Overweight rating on the shares. Q3 showed an intact recovery…
Centene price target raised to $72 from $69 at Mizuho
Mizuho raised the firm’s price target on Centene (CNC) to $72 from $69 and keeps a Neutral rating on the shares.
Centene price target raised to $71 from $66 at Baird
Baird analyst Michael Ha raised the firm’s price target on Centene (CNC) to $71 from $66 and keeps a Neutral rating on the shares.The firm updated its model as the…
Centene price target raised to $82 from $80 at BofA
BofA analyst Kevin Fischbeck raised the firm’s price target on Centene (CNC) to $82 from $80 and keeps a Buy rating on the shares after its Q3 earnings beat and…
Centene Earnings Call Transcript: Q3 2026
Q3 adjusted EPS of $0.58 beat expectations, raising 2026 guidance above $5.20. Medicare and Marketplace strength offset Medicaid membership and policy pressures, while management expects 2027 earnings growth.
Centene Earnings release: Q3 2026
Centene released its Q3 2026 earnings on October 27, 2026, summarizing the period's financial results.
Centene Quarterly report: Q3 2026
Centene has published its Q3 2026 quarterly earnings report on October 27, 2026.
Centene Lifts 2026 Guidance Amid Medicare Cost Controls
For third quarter, the healthcare company reported a net loss of $71 million, or 14 cents a share, compared with a loss of $6.63 billion, or $13.50 a share, a year ago.
Centene ups FY26 adjusted EPS view to greater than $5.20 from greater than $4.80
Consensus $4.88. Raises FY26 revenue view to $196.5B-$200.5B from $193.5B-$197.5B, consensus $195.92B. The company said, “The Company is updating its 2026 GAAP diluted EPS guidance floor to greater th...
Centene reports Q3 adjusted EPS 58c, consensus 10c
Reports Q3 revenue $50.65B, consensus $46.95B. “Solid underlying fundamentals within our core businesses have powered a faster recovery to our earnings trajectory than previously anticipated,” said Ch...
CENTENE CORPORATION REPORTS THIRD QUARTER 2026 RESULTS
-- Third Quarter GAAP Diluted Loss Per Share of $(0.14); Adjusted Diluted Earnings Per Share of $0.58 -- -- Increases 2026 GAAP Diluted EPS Guidance: Greater than $3.46 & Adjusted Diluted EPS Greater ...
Ambetter Health Announces 2027 Marketplace Offerings, Including Enhanced Condition-Specific Coverage Options
Ambetter Health Introduces New Heart Failure Coverage and Expands Chronic Care Solutions in Nine States ST. LOUIS, Oct. 20, 2026 /PRNewswire/ -- Ambetter Health, the Health Insurance Marketplace produ...
CENTENE CORPORATION TO HOST 2026 THIRD QUARTER FINANCIAL RESULTS EARNINGS CALL
ST. LOUIS, Oct. 19, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 t...
Centene Corporation Demonstrates Commitment to CHOICE Arrangements through Benefit Programs in Indiana, Ohio and Oklahoma
Expansion into Ohio and Oklahoma for plan year 2027 builds on early success offering employees CHOICE Arrangements in Indiana in 2026 ST. LOUIS, Oct. 16, 2026 /PRNewswire/ -- Centene Corporation (NYS...
PA Health & Wellness Earns National Recognition Among Top Medicaid Health Plans for Second Consecutive Year
MECHANICSBURG, Pa., Oct. 13, 2026 /PRNewswire/ -- PA Health & Wellness, a leading managed care organization in Pennsylvania and a company of Centene Corporation (NYSE: CNC), today announced that it ha...
Centene to Launch Nationwide Gold Card Program for Qualifying Providers
ST. LOUIS, Oct. 13, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced it will launch its National Performance-Based Gold Card Program in November 2026. The program, which will initi...
Ambetter Health Solutions and Marathon Health Expand Access to Primary Care for Members in Indiana and Missouri
The new partnership will provide eligible members with $0 primary care visits, lab services, and virtual care beginning in 2027 ST. LOUIS, Oct. 7, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC),...
Wellcare Unveils 2027 Medicare Offerings Focused on Affordability and Integrated Care
2027 Wellcare portfolio brings together affordable Medicare coverage and innovative supplemental benefits combined with the nation's largest standalone Medicare Part D platform Provides coordinated Me...
Health Net Providing Special Assistance to Members and Providers Affected by Weather Events Statewide and Robin Lane Sewage Spill in Lake County
SACRAMENTO, Calif., Sept. 22, 2026 /PRNewswire/ -- Following Gov.
Stockton Seniors Gain Access to 76 Affordable Homes with Health Net's $3 Million Investment
Mutual Housing California's Fairview Terrace will help income-qualified older adults in San Joaquin County find stable, affordable housing and remain connected to the community they call home STOCKTON...
Centene Transcript: Deutsche Bank 2026 Healthcare Summit
Guidance for 2026 EPS and margins across Medicaid, Medicare, Part D, and ACA was reaffirmed, with trends and rates developing as expected. Medicaid and Medicare are focused on margin progression, portfolio simplification, and adapting to policy changes, while ACA and Part D maintain strong margin targets. Corporate restructuring and leadership transitions are underway to support future growth.